Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
EPS (Diluted)
Meridian Bioscience Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
EPS (Diluted)
$0
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
EPS (Diluted)
$1
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-13%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
EPS (Diluted)
$6
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
EPS (Diluted)
$6
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's EPS (Diluted)?
EPS (Diluted)
1
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's EPS (Diluted) amounts to 1 USD.
What is Meridian Bioscience Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
13%
Over the last year, the EPS (Diluted) growth was -41%. The average annual EPS (Diluted) growth rates for Meridian Bioscience Inc have been 19% over the past three years , 13% over the past five years .